An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 3 , ISSUE 2 ( May-August, 2011 ) > List of Articles

CASE REPORT

Brain Metastases Secondary to Advanced Laryngeal Cancer Presenting as Diminution of Vision and Lower Limb Weakness

Rauf Ahmad, Syed Majid Hussain, Mukhtar Ahmad

Keywords : Brain metastases,Primary laryngeal cancer,CT scan,Distant metastases,Head and neck cancer

Citation Information : Ahmad R, Hussain SM, Ahmad M. Brain Metastases Secondary to Advanced Laryngeal Cancer Presenting as Diminution of Vision and Lower Limb Weakness. Int J Otorhinolaryngol Clin 2011; 3 (2):117-121.

DOI: 10.5005/jp-journals-10003-1068

Published Online: 01-08-2011

Copyright Statement:  Copyright © 2011; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Objective

Intracranial metastases from primary laryngeal carcinoma are extremely rare and to present as diminution of vision has not been reported in published English literature. We present a case of advanced laryngeal carcinoma, who after treatment with surgery and chemo radiation, presented with decreased vision and weakness of lower limbs secondary to brain metastases.

Case report

A 35-year-old male presented with dysphonia and L upper neck swelling. Endoscopy revealed a left supraglottic mass with fixed vocal cord and pathology of primary site and neck swelling reported it as moderately differentiated squamous cell carcinoma. Clinical and radiological assessment staged the tumor as T3N2bM0. Patient underwent combined standard surgical and medical treatment. Eight months after completion of treatment patient presented as decreased visual acuity (R > L) and gradually progressing weakness of lower limbs. Evidence of papilloedema on fundus exam prompted an urgent CT brain which showed multiple metastatic deposits in brain. There was no evidence of metastases in lungs, bones or liver.

Conclusion

Brain metastases are a known entity in Head and Neck cancer. Larynx as a primary site for the same should be kept in consideration with an atypical presentation as in present case.


PDF Share
  1. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;110(3):397–401.
  2. Distant metastases from head and neck cancer. Cancer 1984;53:342–45.
  3. Laryngeal squamous cell carcinoma with infra diaphragmatic presentation of skin metastases. Clin and Exp Dermatology 2006;31(2):242–44.
  4. Distant muscular (rectus femoris) metastases from laryngeal squamous cell carcinoma. J Laryngo Otol Dec 2009;123(12):1381–83.
  5. Distant muscular (gluteus maximus) metastases from laryngeal squamous cell carcinoma. Acta Otolaryngol Jun 2005;125(6):678–82.
  6. Isolated skeletal muscle metastases following successful treatment of laryngeal cancer: Case report. Int Semin Surg Oncol 2010;7:1.
  7. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71:452–56.
  8. Intracranial metastases in patients with squamous cell carcinoma of the head and neck. Otolaryngol Head and Neck Surgery 2001;124(2): 217–21.
  9. Isolated intracranial metastases from an early glottis cancer: How rare a presentation? Ind J Otolaryngol Head and Neck Surg 2010;61(1):62–65.
  10. Cavernous sinus metastasis from oropharyngeal squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2007;12:E166–70.
  11. Detection of metastases from head and neck cancers. Laryngoscope 1995;105(3):247–50.
  12. Detection of brain metastases: Comparison of contrast enhanced MR with unenhanced MR and enhanced CT. Am J Neuroradiol 1990;11(4):785–91.
  13. High-dose cisplatin in advanced head and neck cancer. Cancer Chemother Pharmacol 1987;19:155.
  14. High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase II pilot study. Cancer 1989;63:423.
  15. Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. Eur J Cancer 2004;40:2071.
  16. Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol 1994;5:533.
  17. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992;10:257.
  18. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007;25:2171.
  19. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002;20:3644.
  20. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial. Int J Radiat Oncol Biol Phys 2005;61:185.
  21. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol Jan 2010;96(1):17-32.
  22. The role of surgical resection in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol Jan 2010;96(1):33-43.
  23. The role of chemotherapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol. Jan 2010;96(1):71-83.
  24. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol Jan 2010;96(1):45-68.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.